Company profile: IDbyDNA
1.1 - Company Overview
Company description
- Provider of precision metagenomics to uncover the microbial world, aiming to bring the precision seen in cancer care to infectious disease patients.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to IDbyDNA
Cergentis
HQ: The Netherlands
Website
- Description: Provider of services and kits based on proprietary Targeted Locus Amplification (TLA) technology, enabling cost-effective complete sequencing of relevant genes and genomic loci and providing genetic characterization and quality control (QC) to support the development of advanced, safe and effective therapies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cergentis company profile →
MyoNexus Therapeutics
HQ: United States
Website
- Description: Provider of clinical-stage gene therapies for limb-girdle muscular dystrophy (LGMD) types 2D, 2B, 2E, 2L, and 2C based on research at Nationwide Children’s Hospital; RNA exon-skipping technologies for rare diseases, particularly Duchenne muscular dystrophy, using PMO with next-generation PPMO in development; gene editing research; and precision genetic medicine platforms for Charcot-Marie-Tooth disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MyoNexus Therapeutics company profile →
Locus Biosciences
HQ: United States
Website
- Description: Provider of CRISPR-engineered precision antibacterial therapies using bacteriophages. Portfolio includes LBP-EC01 for E. coli urinary tract infections; LBP-PA01 and LBP-SA01 targeting P. aeruginosa and S. aureus with Janssen; and LBP-KP01 for K. pneumoniae supported by CARB-X. Also offers robotic bacteriophage discovery and synthetic biology to engineer phage products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Locus Biosciences company profile →
Genprex
HQ: United States
Website
- Description: Provider of clinical-stage immunogene therapies and diabetes gene therapy candidates: REQORSA for non-small and small cell lung cancer using the ONCOPREX nanoparticle system to deliver the TUSC2 tumor suppressor gene; GPX-002 for Type 1 Diabetes via AAV delivery of Pdx1 and MafA to convert alpha cells to beta-like cells; and GPX-003 for Type 2 Diabetes targeting beta cell replenishment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Genprex company profile →
CellforCure
HQ: France
Website
- Description: Provider of advanced therapy medicinal product expertise as a key industrial and innovative player in the field.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CellforCure company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for IDbyDNA
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to IDbyDNA
2.2 - Growth funds investing in similar companies to IDbyDNA
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for IDbyDNA
4.2 - Public trading comparable groups for IDbyDNA
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →